Novel approach uses patient's cells as "trojan horse" to target lung cancer cells
View as a Web Page
News Medical
 
  Respiratory Diseases Respiratory Diseases logo  
  The latest respiratory diseases news from News Medical  
 Scientists uncover a new doorway for SARS-CoV-2 into human cellsScientists uncover a new doorway for SARS-CoV-2 into human cells
 
Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.		 
 
 Novel approach uses patient's cells as "trojan horse" to target lung cancer cellsNovel approach uses patient's cells as "trojan horse" to target lung cancer cells
 
Lung cancer is not the most common form of cancer, but it is by far the deadliest.		 
 
 How did COVID-19 impact cancer incidence trends in the US?How did COVID-19 impact cancer incidence trends in the US?
 
Cancer rate patterns from March to December 2020.		 
 
    No Smoking Day: UK ‘Smokefree’ by 2030No Smoking Day: UK ‘Smokefree’ by 2030
 
Discover how the Smokerlyzer® range of carbon monoxide (CO) breath analysis devices for smoking cessation have been helping people quit smoking one breath at a time for over 35 years; aligning with the UK government’s plan for the UK to become ‘smokefree’ by 2030.
 
Find Out More
 
 
   Fine particulate matter exposure linked to increased hospital admissions for major diseasesFine particulate matter exposure linked to increased hospital admissions for major diseases
 
Short and long term exposure to fine particulate matter (PM2.5) air pollution is linked to an increased risk of hospital admission for major heart and lung diseases, find two large US studies, published by The BMJ today.		 
   Natural killer cells lead the charge in cancer treatment innovationNatural killer cells lead the charge in cancer treatment innovation
 
Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.		 
   Researchers develop new tool to rapidly and inexpensively diagnose sarcoidosisResearchers develop new tool to rapidly and inexpensively diagnose sarcoidosis
 
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs in the body.		 
   Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activityCombo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity
 
Researchers evaluated rational combination treatment regimens for advanced/metastatic non-small-cell lung cancer (NSCLC).		 
   Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasivelyStudy suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively
 
Researchers developed an artificial intelligence (AI)-based predictive system (AIPS) model for the early detection of lung cancer by combining radiological, clinical, and genetic data.		 
   Genetic signature may help predict disease-free survival in patients with non-small cell lung cancerGenetic signature may help predict disease-free survival in patients with non-small cell lung cancer
 
A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation.		 
 UK lags in cancer treatment compared to other countries
 
UK lags in cancer treatment compared to other countriesPeople in the UK were treated with chemotherapy and radiotherapy less often than in comparable countries and faced long waits for treatments, according to two new studies published in The Lancet Oncology.		 
 
 Insights into influenza vaccine types and manufacturing process
 
In this article, you will gain insights into the various Influenza vaccine types and the manufacturing processes that underlie them.		 
 
 Study highlights health care disparities for Nunavik Inuit inhabitants with lung cancer
 
Study highlights health care disparities for Nunavik Inuit inhabitants with lung cancerPeople living in the Inuit region of Nunavik in northern Quebec die earlier after a diagnosis of lung cancer than Montreal residents receiving treatment at the same cancer centre, according to new research published in CMAJ.		 
 
 A deep dive into immuno-oncology: unraveling cancer types and confronting challenges
 
This article will uncover the rich history, various cancer types, and hurdles encountered in the ever-evolving field of Immuno-Oncology.		 
 
 Impact of diet on health outcomes among United Kingdom Biobank participants
 
Impact of diet on health outcomes among United Kingdom Biobank participantsThe association between diet and health outcomes among United Kingdom Biobank (UKBB) participants.		 
 
 Green tea does not lower the risk of lung cancer
 
Green tea does not lower the risk of lung cancerWhether green tea consumption was associated with a lower risk of lung cancer.		 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025